Pharmacological effects of SCH 30497--a novel analgesic substance.

Abstract

SCH 30497 (2-[3-(1,2,3,6-tetrahydro-4-2(methylphenyl)-pyridin-1-yl) -propyl]-1,2,4-triazolo[4,3-a] pyridin-3-(2H)-one) was tested for analgesic effects in the rat, mouse and squirrel monkey. SCH 30497 showed dose-related analgesic effects in the rat yeast-paw test; at peak times the ED7sec (95% confidence limits) in mg/kg via the oral, subcutaneous, intramuscular and intravenous routes of administration were as follows, respectively: 4.7 (2.1-9.8), 5.7 (3.4-9.6), 6.4 (4.1-9.8) and 1.4 (0.6-3.2). SCH 30497 was also analgesic in the acetic acid-induced writhing test in mice (ED50 = 1.9 mg/kg p.o.) and the squirrel monkey shock titration test (ED50 = 14.5 mg/kg p.o.). It was inactive in the mouse (100 mg/kg p.o.) and rat (40 mg/kg p.o.) tail-flick tests. Thus, SCH 30497 was efficacious versus chemical, mechanical and electrical nociceptive stimuli. Naloxone antagonism of the analgesic effects of SCH 30497 was species specific with significant inhibition observed only in the rat and not in the mouse or monkey. SCH 30497 did not produce Straub tail or hyperactivity in mice. Twice daily dosing at 30 mg/kg p.o. to rats for 5 days failed to produce tolerance; in separate experiments, daily injections for 10 days at 20 or 100 mg/kg p.o. failed to induce signs of dependence following naloxone challenge. SCH 30497-induced analgesia was not attenuated in rats previously made tolerant to narcotics by implantation of a morphine pellet. SCH 30497 showed a weak ability to displace 3H-Met5-enkephalin from its binding sites on rat brain membranes (IC50 = 48 microM). SCH 30497 (100 microM) did not affect prostaglandin synthesis in vitro. In vivo, the drug did not have anti-inflammatory or ulcerogenic effects up to 80 mg/kg p.o. Acute behavioral, neurological and autonomic side effects were primarily depressant in rodents and occurred at doses greater than 15 times those that were analgesically relevant. Moderate doses in the monkey (2.5 times the ED50) and high doses in mice produced convulsions. It is hypothesized that SCH 30497-like drugs represent a new class of analgesics based on this unique pharmacological spectrum of activity.

• Authors: R E Chipkin, M B Latranyi, L C Iorio, A Barnett, J G Berger
• Journal: Archives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 278 Issue 1 Pg. 23-44 (Nov 1985) ISSN: 0003-9780 [Print] Belgium
• PMID: 3006616 (Publication Type: Journal Article)

Chemical References

• Acetates
• Anti-Inflammatory Agents, Non-Steroidal
• Narcotics
• Prostaglandins
• Receptors, Opioid
• Triazoles
• Sch 30497
• Acetic Acid

Topics

• Acetates
• Acetic Acid
• Animals
• Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
• Autonomic Nervous System (drug effects)
• Drug Tolerance
• Electroshock
• Inflammation (chemically induced)
• Male
• Mice
• Narcotics (pharmacology)
• Pain (chemically induced)
• Prostaglandins (biosynthesis)
• Rats
• Rats, Inbred Strains
• Reaction Time (drug effects)
• Receptors, Opioid (drug effects)
• Saimiri
• Triazoles (pharmacology)